Literature DB >> 25228399

Central emboli rather than saddle emboli predict adverse outcomes in patients with acute pulmonary embolism.

Keum-Ju Choi1, Seung-Ick Cha2, Kyung-Min Shin3, Jae-Kwang Lim3, Seung-Soo Yoo1, Jaehee Lee1, Shin-Yup Lee1, Chang-Ho Kim1, Jae-Yong Park1, Won-Kee Lee4.   

Abstract

INTRODUCTION: In patients with acute pulmonary embolism (PE), the prognostic implications of saddle or central emboli, as observed on computed tomography (CT), remain to be established. The aim of the present study was to assess whether the presence of saddle and central emboli could be used to predict clinical outcomes in patients with PE.
MATERIALS AND METHODS: The authors retrospectively reviewed 743 consecutive patients hospitalized at a tertiary referral center with a diagnosis of PE based on multi-detector row CT scan.
RESULTS: All the clinical variables did not differ between saddle emboli (5.8% [n = 43]) and right or left pulmonary artery emboli (29.7% [n = 221]), and the frequency of an adverse outcome was not significantly different between the two groups. Saddle emboli and right or left pulmonary artery emboli were grouped into central emboli (35.5% [n = 264]). Patients were allocated to an adverse outcome group (10.5% [n = 78]) or a control group (89.5% [n = 665]). Multivariate analysis demonstrated that PE severity index (PESI) score (class IV-V), N-terminal-pro-B-type natriuretic peptide level (≥ 1,406 pg/mL), right ventricular dilation on CT (right ventricle/left ventricle diameter ratio ≥ 1), and central emboli significantly predicted an adverse outcome. The addition of central emboli to other established prognostic factors such as PESI enhanced the positive predictive values and positive likelihood ratios of an adverse outcome for acute PE.
CONCLUSIONS: Rather than saddle emboli, central emboli could be an independent prognostic factor of adverse outcomes in patients with acute PE and provide additional prognostic value when combined with other prognostic factors.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography; Prognosis; Pulmonary arteries; Pulmonary embolism

Mesh:

Substances:

Year:  2014        PMID: 25228399     DOI: 10.1016/j.thromres.2014.08.027

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Treatment of Submassive Pulmonary Embolism: Knowing When to be Aggressive and When to be Conservative.

Authors:  David L Ain; Michael R Jaff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

2.  Detection of Deep Vein Thrombosis by Follow-up Indirect Computed Tomography Venography after Pulmonary Embolism.

Authors:  Hye Jin Lee; Seung Ick Cha; Kyung Min Shin; Jae Kwang Lim; Seung Soo Yoo; Shin Yup Lee; Jaehee Lee; Chang Ho Kim; Jae Yong Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-12-13

3.  A decision tree built with parameters obtained by computed tomographic pulmonary angiography is useful for predicting adverse outcomes in non-high-risk acute pulmonary embolism patients.

Authors:  Dong Jia; Xue-Lian Li; Qin Zhang; Gang Hou; Xiao-Ming Zhou; Jian Kang
Journal:  Respir Res       Date:  2019-08-19

4.  Concurrence of Gastric Cancer and Incidental Pulmonary Embolism May Be a Prognostic Factor for Advanced Gastric Cancer Patients with Incidental Pulmonary Embolism.

Authors:  Meiqing Qiu; Ying Meng; Huijun Wang; Li Sun; Zhen Liu; Shifeng Kan; Tao Wang; Shu Zhang
Journal:  Cancer Manag Res       Date:  2021-10-04       Impact factor: 3.989

5.  Frequency of spontaneous detection of pulmonary arterial thrombi in unenhanced chest computed tomography in patients diagnosed with pulmonary embolism.

Authors:  Pedro Paulo Teixeira E Silva Torres; Marcelo Fouad Rabahi; Alexandre Dias Mançano; Silvia Helena Rabelo Dos Santos; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2022-03-14       Impact factor: 2.624

6.  Pulmonary embolism concurrent with lung cancer and central emboli predict mortality in patients with lung cancer and pulmonary embolism.

Authors:  Seung-Ick Cha; Kyung-Min Shin; Jae-Kwang Lim; Seung-Soo Yoo; Shin-Yup Lee; Jaehee Lee; Chang-Ho Kim; Jae-Yong Park; Won-Kee Lee; Chi-Young Jung
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.